Published in TB and Outbreaks Week, July 8th, 2003
According to published research from the United States, a "cross-sectional study of 110 individuals examined skin testing for latent tuberculosis infection (LTBI) after the initiation of highly active antiretroviral therapy."
"Skin test reactivity to one or more of four antigens was found in 98 out of 110 subjects (89%)," according to T.L. Fisk and colleagues at Emory University.
Test results showed that tuberculin reactivity was "maximal in those whose CD4 cell counts recovered to greater than or equal to 100...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week